SG90086A1 - Aryl caboxylic acid and tetrazole derivatives - Google Patents

Aryl caboxylic acid and tetrazole derivatives

Info

Publication number
SG90086A1
SG90086A1 SG9906425A SG1999006425A SG90086A1 SG 90086 A1 SG90086 A1 SG 90086A1 SG 9906425 A SG9906425 A SG 9906425A SG 1999006425 A SG1999006425 A SG 1999006425A SG 90086 A1 SG90086 A1 SG 90086A1
Authority
SG
Singapore
Prior art keywords
aryl
tetrazole derivatives
caboxylic acid
caboxylic
acid
Prior art date
Application number
SG9906425A
Other languages
English (en)
Inventor
Javier Lopez-Tapia Francisco
Victor Muehldorf Alexander
O'yang Counde
Lee Severance Daniel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG90086A1 publication Critical patent/SG90086A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
SG9906425A 1998-12-23 1999-12-17 Aryl caboxylic acid and tetrazole derivatives SG90086A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11344698P 1998-12-23 1998-12-23
US15181499P 1999-08-30 1999-08-30

Publications (1)

Publication Number Publication Date
SG90086A1 true SG90086A1 (en) 2002-07-23

Family

ID=26811078

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9906425A SG90086A1 (en) 1998-12-23 1999-12-17 Aryl caboxylic acid and tetrazole derivatives

Country Status (29)

Country Link
US (1) US6335459B1 (fr)
EP (1) EP1013639B1 (fr)
JP (1) JP3415085B2 (fr)
KR (1) KR100378335B1 (fr)
CN (1) CN1167670C (fr)
AR (1) AR029320A1 (fr)
AT (1) ATE251125T1 (fr)
AU (1) AU735640B2 (fr)
BR (1) BR9905974A (fr)
CA (1) CA2292921C (fr)
DE (1) DE69911726T2 (fr)
DK (1) DK1013639T3 (fr)
ES (1) ES2207108T3 (fr)
HR (1) HRP990394A2 (fr)
HU (1) HUP9904659A3 (fr)
ID (1) ID25983A (fr)
IL (1) IL133578A (fr)
MA (1) MA26713A1 (fr)
NO (1) NO316171B1 (fr)
NZ (1) NZ501891A (fr)
PE (1) PE20001368A1 (fr)
PL (1) PL337419A1 (fr)
PT (1) PT1013639E (fr)
RU (1) RU2179969C2 (fr)
SG (1) SG90086A1 (fr)
TR (1) TR199903310A2 (fr)
TW (1) TWI221834B (fr)
UY (1) UY25876A1 (fr)
YU (1) YU69699A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
SE0100158D0 (sv) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere´s disease and tinnitus
CN1280289C (zh) * 2001-03-02 2006-10-18 弗·哈夫曼-拉罗切有限公司 用作ip拮抗剂的烷氧基羰基氨基杂芳基羧酸衍生物
US20060217421A1 (en) 2003-05-09 2006-09-28 Hajimu Kurumatani Fortifier
UA93548C2 (uk) 2006-05-05 2011-02-25 Айерем Елелсі Сполуки та композиції як модулятори хеджхогівського сигнального шляху
US9669381B2 (en) 2007-06-27 2017-06-06 Hrd Corporation System and process for hydrocracking
RS53684B9 (sr) 2008-03-18 2019-07-31 Arena Pharm Inc Modulatori prostaciklinskog (pgi2) receptora korisnih u tretmanu poremećaja vezanih za pgi2
MY163762A (en) 2008-07-23 2017-10-31 Toray Industries Therapeutic agent for chronic renal failure
CA2936749C (fr) 2010-06-11 2019-07-09 Joshua R. Giguere Procedes catalyses par metal de transition pour la preparation de composes de n-allyle et utilisation de ceux-ci
EP2580218B1 (fr) 2010-06-11 2015-02-25 Rhodes Technologies Traitement de n-désalkylation d'amines tertiaires
KR102432505B1 (ko) 2017-03-01 2022-08-12 아레나 파마슈티칼스, 인크. Pgi2-수용체 효능제를 포함하는 조성물 및 그의 제조 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832859A (ja) * 1981-08-20 1983-02-25 Dainippon Pharmaceut Co Ltd Ｎ，ｎ−ジメチルカルバミン酸ベンジルエステル誘導体
EP0558062A2 (fr) * 1992-02-28 1993-09-01 Ono Pharmaceutical Co., Ltd. Dérivés d'acide phénoxyacétique et compositions pharmaceutiques les contenant

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1079414A (en) 1965-06-30 1967-08-16 Smith & Nephew Derivatives of acetic acid and a process for their preparation
GB1185539A (en) 1967-11-03 1970-03-25 Smith & Nephew Substituted Tetrazoles
DE2432560A1 (de) 1974-07-06 1976-01-22 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeurederivate und verfahren zur herstellung derselben
JPH0725725B2 (ja) 1987-07-23 1995-03-22 保土谷化学工業株式会社 ベンズアミド誘導体
US5084466A (en) 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2183063A1 (fr) 1994-02-10 1995-08-17 Atsushi Ichikawa Recepteur de la prostaglandine i2
ES2160156T3 (es) 1994-03-10 2001-11-01 Fujisawa Pharmaceutical Co Derivados de naftaleno como agonistas de la prostaglandina i2.
US5753700A (en) 1994-12-28 1998-05-19 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
US6018068A (en) 1995-07-26 2000-01-25 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives and drugs comprising the same as active ingredients
AUPP029197A0 (en) 1997-11-10 1997-12-04 Fujisawa Pharmaceutical Co., Ltd. Benzocycloheptene derivatives
AUPP109097A0 (en) 1997-12-22 1998-01-22 Fujisawa Pharmaceutical Co., Ltd. Napthalene derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832859A (ja) * 1981-08-20 1983-02-25 Dainippon Pharmaceut Co Ltd Ｎ，ｎ−ジメチルカルバミン酸ベンジルエステル誘導体
EP0558062A2 (fr) * 1992-02-28 1993-09-01 Ono Pharmaceutical Co., Ltd. Dérivés d'acide phénoxyacétique et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
HRP990394A2 (en) 2000-08-31
HUP9904659A2 (hu) 2000-11-28
YU69699A (sh) 2001-12-26
ATE251125T1 (de) 2003-10-15
US6335459B1 (en) 2002-01-01
TR199903310A3 (tr) 2000-10-23
RU2179969C2 (ru) 2002-02-27
CA2292921A1 (fr) 2000-06-23
PL337419A1 (en) 2000-07-03
AU735640B2 (en) 2001-07-12
IL133578A0 (en) 2001-04-30
DK1013639T3 (da) 2004-02-09
AU6534099A (en) 2000-07-06
TR199903310A2 (xx) 2000-10-23
JP3415085B2 (ja) 2003-06-09
ES2207108T3 (es) 2004-05-16
CN1266054A (zh) 2000-09-13
KR100378335B1 (ko) 2003-03-29
IL133578A (en) 2004-07-25
TWI221834B (en) 2004-10-11
ID25983A (id) 2000-11-16
PE20001368A1 (es) 2000-12-14
DE69911726T2 (de) 2004-07-29
NO996366D0 (no) 1999-12-21
PT1013639E (pt) 2004-02-27
JP2000191523A (ja) 2000-07-11
MA26713A1 (fr) 2004-12-20
CN1167670C (zh) 2004-09-22
HU9904659D0 (en) 2000-02-28
EP1013639B1 (fr) 2003-10-01
UY25876A1 (es) 2001-07-31
HUP9904659A3 (en) 2000-12-28
BR9905974A (pt) 2000-09-12
EP1013639A1 (fr) 2000-06-28
AR029320A1 (es) 2003-06-25
CA2292921C (fr) 2004-08-17
NZ501891A (en) 2001-10-26
DE69911726D1 (de) 2003-11-06
KR20000048322A (ko) 2000-07-25
NO316171B1 (no) 2003-12-22
NO996366L (no) 2000-06-26

Similar Documents

Publication Publication Date Title
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
PL334997A1 (en) Derivatives or arylosulphonyl-hydroxamic acid
GB9907263D0 (en) Amino acid derivatives
HK1035525A1 (en) Aminomethylcarboxylic acid derivatives
EG24140A (en) New 3-aryl-2-hydroxypropionic acid derivative
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
HUP0003881A3 (en) Amidocarboxylic acid derivatives
HRP980438B1 (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
EP1024130A4 (fr) Derives de biphenyl-5-acide alcanoique et leurs applications
EP1223932A4 (fr) Composes et methodes
EP1146790A4 (fr) Composes et procedes
ZA994406B (en) Meta-azacyclic amino benzoic acid and derivatives thereof.
AU1177300A (en) Thiocarbamic acid derivatives
IL147216A0 (en) Arylsulfonamido-substituted hydroxamic acid derivatives
HK1054038A1 (en) Substituted n-benzyl-indol-3-yl gloyoxylic acid derivatives having an antitumural effect
IL137330A0 (en) Novel dihydroxyhexanoic acid derivatives
AU1559199A (en) Isothiazolcarboxylic acid derivatives
SG90086A1 (en) Aryl caboxylic acid and tetrazole derivatives
AU1268400A (en) Isothiazolecarboxylic acid derivatives
GB9929979D0 (en) Hydroxamic acid derivatives
AU5289299A (en) Divinylstilbenesulfonic acid derivatives
AUPP355498A0 (en) Salt poultice
HK1039609A1 (zh) 甲氧基亞氨基苯基乙酰胺
AU3960700A (en) Triazolopyrimidinol compounds and salts thereof
ZA997773B (en) Aryl carboxylic acid and tetrazole derivatives.